Biggest News Aggregation in the World
📰 After Part News

After Part News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from After Part. Real-time updates on events, politics, business and more.

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Additional 18-Months of Continued Treatment Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia

Oral presentation at American Society of Hematology (ASH) Annual Meeting highlights continued favorable safety and tolerability profile and sustained long-term efficacy results for SerpinPC: 93%
United States City Of United Kingdom Trevor Baglin Medsc Kristenk Sheppard American Society Of Hematology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science